Artiva Biotherapeutics (ARTV) Other Gross PP&E Adjustments (2023 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Other Gross PP&E Adjustments for 3 consecutive years, with $14.9 million as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 1090.21% to $14.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.9 million, a 1090.21% increase, with the full-year FY2025 number at $14.9 million, up 1090.21% from a year prior.
- Other Gross PP&E Adjustments was $14.9 million for Q4 2025 at Artiva Biotherapeutics, up from $3.5 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $14.9 million in Q4 2025 to a low of -$4.9 million in Q4 2023.
- A 3-year average of $2.8 million and a median of $724000.0 in 2025 define the central range for Other Gross PP&E Adjustments.
- Biggest YoY gain for Other Gross PP&E Adjustments was 1090.21% in 2025; the steepest drop was 70.38% in 2025.
- Artiva Biotherapeutics' Other Gross PP&E Adjustments stood at -$4.9 million in 2023, then soared by 69.49% to -$1.5 million in 2024, then skyrocketed by 1090.21% to $14.9 million in 2025.
- Per Business Quant, the three most recent readings for ARTV's Other Gross PP&E Adjustments are $14.9 million (Q4 2025), $3.5 million (Q3 2025), and $1.3 million (Q2 2025).